CT62 and malignant glioma: Therefore, the low expression of CT62, DPY19L2P1, KCNH1‐IT1 and VPS33B in malignant glioma would promote the formation of M2 macrophages and thus promote malignant glioma tumorigenesis and progression (Figure 1B).